{"nct_id":"NCT07190196","title":"A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease","status":"NOT_YET_RECRUITING","status_verified_date":"2025-09","start_date":"2025-09-18","start_date_type":"ESTIMATED","primary_completion_date":"2028-06-28","primary_completion_date_type":"ESTIMATED","completion_date":"2030-12-25","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["SNY"]}